In-vitro characterisation of the nebulised dose during non-invasive ventilation

Journal of Pharmacy and Pharmacology

Volumn 62, Issue 8, 2010, Pages 966-972

  Abdelrahim, Mohamed E ^a   Plant, Paul ^b   Chrystyn, Henry ^c  

^a BENI SUEF UNIVERSITY   (Egypt)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

aerodynamic characteristics; nebuliser; Next Generation Impactor; non invasive ventilation; terbutaline

Indexed keywords

TERBUTALINE SULFATE;

ARTICLE; ARTIFICIAL VENTILATION; DRUG DELIVERY SYSTEM; EXPIRATORY RESERVE VOLUME; FILTER; IN VITRO STUDY; INSPIRATORY CAPACITY; MEDICAL NEBULIZER; NEBULIZATION; NON INVASIVE PROCEDURE; NON INVASIVE VENTILATION; PARTICLE SIZE; SIMULATION; SIMULATOR; TIDAL VOLUME; VENTILATOR;

ADMINISTRATION, INHALATION; AEROSOLS; BRONCHODILATOR AGENTS; EQUIPMENT DESIGN; EXHALATION; HUMANS; INHALATION; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; PRESSURE; PULMONARY VENTILATION; RESPIRATION, ARTIFICIAL; TERBUTALINE; VIBRATION;

EID: 77954909965     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2010.01134.x     Document Type: Article

References (26)

1. Plant PK, Elliott MW. Non-invasive ventilation in acute exacerbations of COPD. Q J Med 1998 91 : 657 660.
2. Chevrolet JC et al. Nasal positive pressure ventilation in patients with acute respiratory failure. Difficult and time-consuming procedure for nurses. Chest 1991 100 : 775 782.
3. Gay PC et al. Metered dose inhalers for bronchodilator delivery in intubated, mechanically ventilated patients. Chest 1991 99 : 66 71.
4. Manthous CA et al. Metered-dose inhaler versus nebulized albuterol in mechanically ventilated patients. Am Rev Respir Dis 1993 148 : 1567 1570.
5. Dhand R, Tobin MJ. Inhaled bronchodilator therapy in mechanically ventilated patients. Am J Respir Crit Care Med 1997 156 : 3 10.
6. Parkes SN, Bersten AD. Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask. Thorax 1997 52 : 171 175.
7. Nava S et al. Salbutamol delivery during non-invasive mechanical ventilation in patients with chronic obstructive pulmonary disease: a randomized, controlled study. Intensive Care Med 2001 27 : 1627 1635.
8. Boe J et al. Guidelines on the use of nebulizers: Guidelines prepared by a European Respiratory Society task force on the use of nebulizers. Eur Respir J 2001 18 : 228 242.
9. Smith EC et al. Comparison of twenty three nebulizer/compressor combinations for domiciliary use. Eur Respir J 1995 8 : 1214 1221.
10. Fink J et al. Aerosol delivery during mechanical ventilation with high frequency oscillation: an in vitro evaluation. American College of Chest Physicians Annual Meeting (ACCP) 2001.
11. Fink J et al. In vitro comparison of a novel nebulizer with ultrasonic and pneumatic nebulizers. J Allergy Clin Immunol 2003 111 : S143.
12. Chatmongkolchart S et al. In vitro evaluation of aerosol bronchodilator delivery during noninvasive positive pressure ventilation: Effect of ventilator settings and nebulizer position. Crit Care Med 2002 30 : 2515 2519.
13. Calvert L et al. Enhanced delivery of nebulised salbutamol during non-invasive ventilation. J Pharm Pharmacol 2006 58 : 1553 1557.
14. Branconnier M, Hess D. Albuterol delivery during noninvasive ventilation. Respir Care 2005 50 : 1649.
15. Pedersen KM et al. Factors influencing the in vitro deposition of tobramycin aerosol: a comparison of an ultrasonic nebulizer and a high-frequency vibrating mesh nebulizer. J Aerosol Med 2006 19 : 175 183.
16. Comité-Européen-Normalisation. Respiratory therapy equipment - Part 1: Nebulizing systems and their components. prEN 13544-1. Brussels, Belgium: CEN, 2001 : 33 38.
17. Berg E, Svensson JO, Asking L. Determination of nebulizer droplet size distribution: a method based on impactor refrigeration. J Aerosol Med 2007 20 : 97 104.
18. Berg E et al. Assessment of the need to coat particle collection cups of the NGI to mitigate droplet bounce when evaluating nebuliser-produced droplets. PharmEuropa Sci Notes 2008 1 : 21 26.
19. Berg E. et al. European Pharmaceutical Aerosol Group (EPAG) Nebuliser Sub-Team: assessment of the need to coat collection cup surfaces of the Next Generation Impactor (NGI) to mitigate droplet bounce. J Aerosol Med 2007 20 : 83.
20. Marple V et al. Next Generation Pharmaceutical Impactor: a new impactor for pharmaceutical inhaler testing. Part III. Extension of archival calibration to 15 l/min. J Aerosol Med 2004 17 : 335 343.
21. Abdelrahim ME, Chrystyn H. Aerodynamic characteristics of nebulized terbutaline sulphate using the Next Generation Impactor (NGI) and CEN method. J Aerosol Med Pulm Drug Deliv 2009 22 : 19 28.
22. Dennis JE et al. Cooling the NGI - an approach to size a nebulised aerosol more accurately. PharmEuropa Sci. Notes 2008 1 : 27 30.
23. Clay MM, Clarke SW. Wastage of drug from nebulisers - a review. J Roy Soc Med 1987 80 : 38 39.
24. Finlay WH, Stapleton KW. Undersizing of droplets from a vented nebulizer caused by aerosol heating during transit through an Anderson impactor. J Aerosol Sci 1999 30 : 105 109.
25. Zhou Y et al. Medical nebulizer performance: effects of cascade impactor temperature. Respir Care 2005 50 : 1077.
26. Hindle M, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmacol 1992 34 : 311 315.